(Q53592368)

16 May 2018

title

Do quality of life assessments make a difference in the evaluation of cancer treatments? (English)

1 reference

16 May 2018

1 reference

C M Moinpour

1

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

16 May 2018

Contemporary Clinical Trials

published in

1 reference

16 May 2018

volume

18

1 reference

16 May 2018

issue

4

1 reference

16 May 2018

page(s)

311-317

1 reference

16 May 2018

Assessing quality of life in comparative cancer clinical trials: does it make a difference?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

A longitudinal study of quality of life in advanced non-small cell lung cancer: Cancer and Leukemia Group B (CALGB) 8931.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

Quality-adjusted survival analysis of malignant glioma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

A quality-of-life-oriented endpoint for comparing therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

Quality of life assessment for cost/utility studies in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

Assessing quality of life in comparative cancer clinical trials: does it make a difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

Karnofsky performance status revisited: reliability, validity, and guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

A validation study of the domains of the core EORTC quality of life questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

More reliable outcome measures can reduce sample size requirements

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

Coefficient alpha and the internal structure of tests

1 reference

https://api.crossref.org/works/10.1016%2FS0197-2456%2897%2900054-8

7 January 2021

10.1016/S0197-2456(97)00054-8

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018